Unclassifiable interstitial lung diseases: Clinical characteristics and survival

Respirology

Volumn 22, Issue 3, 2017, Pages 494-500

  Hyldgaard, Charlotte ^a   Bendstrup, Elisabeth ^a   Wells, Athol U ^b   Hilberg, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

diagnosis; interstitial lung disease; prognosis; survival; unclassifiable

Indexed keywords

ADULT; AGE; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ASSESSMENT OF HUMANS; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CRACKLE; DENMARK; DIFFUSING LUNG CAPACITY FOR CARBON MONOXIDE; DISEASE BEHAVIOUR CLASSIFICATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; GENDER AGE PHYSIOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROGNOSIS; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; SMOKING; SURVIVAL; CHRONIC DISEASE; CLASSIFICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84996773783     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12931     Document Type: Article

References (17)

1. Schweisfurth H, Costabel U, Kropp R. Mitteilung der wissenschaftlichen Arbeitsgemeinschaft fur die Therapie von Lungenkrankheiten: Deutsches Fibroseregister mit ersten Ergebnissen. Pneumologie 1996; 50: 899–901.
2. Agostini C, Albera C, Bariffi F, De Palma M, Harari S, Lusuardi M, Pesci A, Poletti V, Richeldi L, Rizatto G et al. First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch. Chest Dis. 2001; 56: 364–8.
3. Thomeer M, Demedts M, Vandeurzen K, VRGT Working Group on Interstitial Lung Diseases. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin. Belg. 2001; 56: 163–72.
4. Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, Montero C, Sueiro A, Disdier C, Vendrell M. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc. Diffuse Lung Dis. 2004; 21: 64–70.
5. Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir. Med. 2014; 108: 793–9.
6. Cottin V, Wells A. Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Eur. Respir. J. 2013; 42: 576–9.
7. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE Jr, Wolthers PJ et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–7.
8. Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Labrakis C et al. Epidemiology of interstitial lung diseases in Greece. Respir. Med. 2009; 103: 1122–9.
9. Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir. Med. 2004; 98: 567–73.
10. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J, Hegele R, Waldron J, Colby T, Müller N, Lynch D et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2001; 164: 193–6.
11. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733–48.
12. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolthers PJ, Koth LL, King TE Jr et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014; 145: 723–8.
13. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M et al.; HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2003; 168: 952–8.
14. Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–47.
15. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier FJ, Flaherty KR, Lasky JA et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.
16. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.
17. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S et al.; American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1004–14.